CYP1A2 and cancer: Implications of CYP1A1 and CYP1A2 polymorphisms (mainly single-nucleotide polymorphisms—SNPs) have been extensively studied and provide insights into the cancer pathogenesis, risk stratification, response to therapy, and potential therapeutic targets for individuals with specific CYP1A genotypes [109].